Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients with Inflammatory Bowel Disease: No Cause for Concern.
Journal of gastroenterology and hepatology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined